| Title : Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK\/Egr-1 pathway - Wu_2023_FASEB.J_37_e22917 |
| Author(s) : Wu Q , Zhao M , Li D , He X , Zang W |
| Ref : FASEB Journal , 37 :e22917 , 2023 |
| Abstract : Wu_2023_FASEB.J_37_e22917 |
| ESTHER : Wu_2023_FASEB.J_37_e22917 |
| PubMedSearch : Wu_2023_FASEB.J_37_e22917 |
| PubMedID: 37039813 |
Wu Q, Zhao M, Li D, He X, Zang W (2023)
Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK\/Egr-1 pathway
FASEB Journal
37 :e22917
Wu Q, Zhao M, Li D, He X, Zang W (2023)
FASEB Journal
37 :e22917